These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8990659)

  • 41. Molecular characterization of Neisseria meningitidis B:NT:P1.14/162 clonal complex responsible of invasive meningococcal disease in the north of Italy.
    Neri A; Fazio C; Carannante A; Mastrantonio P; Stefanelli P
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):370-2. PubMed ID: 22313628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clusters of meningococcal disease illustrate differences in management of group B and C disease.
    Commun Dis Rep CDR Wkly; 1998 Apr; 8(15):131, 134. PubMed ID: 9599915
    [No Abstract]   [Full Text] [Related]  

  • 43. Spread of meningococcal infection within households.
    Munford RS; Taunay Ade E; de Morais JS; Fraser DW; Feldman RA
    Lancet; 1974 Jun; 1(7869):1275-8. PubMed ID: 4134961
    [No Abstract]   [Full Text] [Related]  

  • 44. [Bacteriological diagnosis of meningococcal infections in children from autopsy material].
    Korzhueva NA; Tsinzerling VA; Kashkin GS; Ioakimova NV
    Lab Delo; 1985; (5):304-6. PubMed ID: 2409342
    [No Abstract]   [Full Text] [Related]  

  • 45. Serogroup Y meningococcal disease in Chicago, 1991-1997.
    Racoosin JA; Whitney CG; Conover CS; Diaz PS
    JAMA; 1998 Dec 23-30; 280(24):2094-8. PubMed ID: 9875877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2020.
    Lahra MM; Shoushtari M; Hogan TR
    Commun Dis Intell (2018); 2020 Nov; 44():. PubMed ID: 33349205
    [No Abstract]   [Full Text] [Related]  

  • 47. Annual report of the Australian Meningococcal Surveillance Programme, 2011.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2012 Sep; 36(3):E251-62. PubMed ID: 23186236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1010-3. PubMed ID: 8965799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meningococcal infections in the Hamilton area during 1978.
    Fawcett S; Achong MR; Adeniyi-Jones C
    Can Med Assoc J; 1980 Mar; 122(5):541-5. PubMed ID: 6768439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The changing epidemiology of meningococcal disease in the United States, 1992-1996.
    Rosenstein NE; Perkins BA; Stephens DS; Lefkowitz L; Cartter ML; Danila R; Cieslak P; Shutt KA; Popovic T; Schuchat A; Harrison LH; Reingold AL
    J Infect Dis; 1999 Dec; 180(6):1894-901. PubMed ID: 10558946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Australian Meningococcal Surveillance Programme annual report, 2013.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E301-8. PubMed ID: 25631592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 53. [Healthy carriers of meningococci. Study of a group of families].
    Linz R; Lecocq E
    Arch Belg Med Soc; 1974 May; 32(5):267-76. PubMed ID: 4215369
    [No Abstract]   [Full Text] [Related]  

  • 54. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
    Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
    J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic susceptibility of invasive Neisseria meningitidis isolates from 1995 to 2008 in Sweden--the meningococcal population remains susceptible.
    Hedberg ST; Olcén P; Fredlund H; Unemo M
    Scand J Infect Dis; 2010; 42(1):61-4. PubMed ID: 19883157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Australian Meningococcal Surveillance Programme quarterly report, 1 April to 30 June 2014.
    Lahra MM
    Commun Dis Intell Q Rep; 2014 Sep; 38(3):E262. PubMed ID: 25391411
    [No Abstract]   [Full Text] [Related]  

  • 57. Annual report of the Australian Meningococcal Surveillance Programme, 2009.
    Australian Meningococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2010 Sep; 34(3):291-302. PubMed ID: 21090184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Invasive pediatric Neisseria meningitidis infections.
    Tuan PL; Li WC; Huang YC; Chiu CH; Lin TY
    J Microbiol Immunol Infect; 2009 Oct; 42(5):427-32. PubMed ID: 20182673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases.
    Edge C; Waight P; Ribeiro S; Borrow R; Ramsay M; Ladhani S
    J Infect; 2016 Nov; 73(5):427-436. PubMed ID: 27475788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CC4821 serogroup W meningococcal disease in China.
    He B; Jia Z; Zhou H; Wang Y; Jiang X; Ma H; Qian Z; Liu X; Shao Z; Chen S; Sun Y
    Int J Infect Dis; 2014 Dec; 29():113-4. PubMed ID: 25461240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.